Cancer Medicine Journal

Journal Home Editorial Board Articles in Press Current Issue Archive Author Guidelines Submit Manuscript

Home

Cancer Medicine Journal (TRIDHA Cancer & Cancer Medicine Society) (DOI prefix: 10.46619) is an International open access, peer-reviewed journal with a broad scope covering all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer.

Cancer Medicine Journal focuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.

At this stage, the submission and publication of manuscripts is at discount for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Acceptance Rate
64%
Days to process
45
Days to publish
10
Total Articles
58

Recently Published Articles

Research Article | Special Issue | Open Access
The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells

Muhammad Wasif Saif, Shrikar Rajagopal, Jennifer Caplain, Martin D Goodman, Daniel Popowich, Bruce A Orkin, Philip N Tsichlis and Robert Martell

Research Article | Special Issue | Open Access
New Potential Options for SBRT in Pancreatic Cancer

Maged Ghaly, Emile Gogineni, Joseph Herman, Muhammad W Saif

Research Article | Special Issue | Open Access
PD-L1 Blockade Immunotherapy with B-Cell Epitope Vaccines Elicit Antitumor Effects in a Syngeneic Tumor Model of Colon Carcinoma

Behnam Sayanjali and Sara Shahnejat Bushehri

Research Article | Special Issue | Open Access
Evaluation of Interventional Role of Nerve Block Procedures in Reduction of Opioid Dose among Cancer Patient in Tertiary Care Cancer Hospital in Pakistan

Irum Ghafoor, Adeel Siddiqui, Haroon Hafeez and Hafiz Muhammad Usman

Mini Review | Special Issue | Open Access
The Functional Architecture of Personalized & Precision Medicine (PPM) Driven by Innovative Strategies to Secure the Clinical Implementation to Cancer Management: Brief Comments

Veronika Medvedeva, Vassiliy Tsytsarev, Maria Studneva, Andrew David Miller, Anton Yuryev and Sergey Suchkov

Case Report | Special Issue | Open Access
Radiotherapy in Mediastinal/Intrapulmonary Malign Solitary Fibrous Tumor: A Case Report

Beyza Sirin Ozdemir

Review Article | Special Issue | Open Access
First Analysis of Same day Pegfilgrastim Use with Concurrent Capecitabine-based Regimens in Patients with Gastrointestinal Malignancies

Muhammad Wasif Saif, Nausheen Hakim, Jeffrey Chi, Hasan Rehman, Shreya Prasad Goyal, Coral Olazagasti, Patnita Forde Sheperd and Jyothi Jose

Review Article | Special Issue | Open Access
Retrospective Analysis of Patients with Gynecological Uterine Sarcomas: Leiomyosarcomas and other Histological Subtypes at a Single Institution from 1996 To 2015

Olger Nano, Maria J Nieto, Muhammad Wasif Saif and Maher Tarabichi

Review Article | Special Issue | Open Access
Breast Body Spray (Bbs) Extraction and Extractor

Mohammad Tariq Qureshi

Editorial | Special Issue | Open Access
Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors

James Newman, Nagashree Seetharamu, and Muhammad Wasif Saif

View More

Aims & Scope

Main aim of the journal is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Cancer Medicine Journal welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.

The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

  • Cancer
  • Cancer Diseases
  • Endocrine disorders
  • Breast cancer
  • Blood diseases
  • Cancer statistics
  • Cancer diagnosis
  • Carcinogenesis - etiology, mechanisms
  • Molecular biology
  • Recent developments in tumor therapy
  • General diagnosis
  • Laboratory diagnosis
  • Diagnostic and experimental pathology
  • Oncologic surgery
  • Epidemiology
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals